Drug firm Strides Arcolab has sold its entire stake (94 percent) in Australian subsidiary Ascent Pharmahealth to Watson Pharmaceuticals for 375 million Australian dollars (over Rs 1,960 crore). Ascent is a leading generic pharmaceutical company in Australia and is present across several countries in South-East Asia, including Singapore. The company intends to focus on its highly attractive steriles segment, which it expects to be their growth engine going forward. The company expects to cut its debt by $250 million. The company's debt-to-equity ratio will fall to 0.6-0.7 from present 1.6. Strides Arcolab has 13 manufacturing facilities across five countries, with a presence in more than 75 countries in developed and emerging markets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: